Placement of the Double-Lumen Tube Without Fiberoptic Bronchoscope Assistance

Therapeutic Procedural Complication Clinical Trial

Official title:

Placement of the Double-Lumen Tube Without Fiberoptic Bronchoscope Assistance

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02943928
• Other study ID #: 2016A123
• Status: Completed
• Phase: N/A
• Start date: October 2016
• Est. completion date: March 2017

Study information

• Verified date: February 2023
• Source: The First Hospital of Qinhuangdao
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

laryngoscope combined with chest CT in double lumen endotracheal tube accurate positioning

Description:

Comparing the traditional method of double lumen endotracheal tube intubation and laryngoscope combined with chest CT guide the precise localization of double lumen endotracheal tube

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: March 2017
• Est. primary completion date: January 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• BMI less than 35 kg/m2
• ASA classifications of I-III, modified Mallampati classification 1 or 2 general anesthesia were included-

Exclusion Criteria:

• Exclusion criteria included age younger than 18 yr
• ASA class IV or V
• Abnormalities of the heart, brain, liver, lung, kidney and coagulation functions-

Related Conditions & MeSH terms

• Therapeutic Procedural Complication

Intervention

Device:
• laryngoscope and chest CT image
First,the operator calculate the distance between the carina and the glottis by CT image and make s marker on the double lumen endotracheal tube. Then the operator when inserted into the double lumen tube under the visualof laryngoscope until see marker just at the glottis
• traditional method by experience
Operator inserted the double lumen tube by experience

Locations

Country	Name	City	State
China	??	Qinhuangdao	Hebei

Sponsors (1)

Lead Sponsor	Collaborator
The First Hospital of Qinhuangdao

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Intubation Time		Ten minutes